The Food and Drug Administration (FDA) warned that certain types of insulin pump systems are vulnerable to cyberattacks. It explained that insulin pumps from medical device company Medtronic [.]
The warning letter was the result of an inspection of the Southern California facility that the FDA completed in July, related to a pair of Class I recalls issued for several models of Medtronic’s MiniMed insulin pumps.